Small Biotech Doubles as Drug Shows Promise in Rare Diseases

(Bloomberg) -- Shares of Allakos Inc. more than doubled after a mid-stage study of its medicine in a pair of rare diseases showed significant improvements for patients.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.